We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+1.69%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$353M
AUM Growth
+$22.9M
Cap. Flow
+$20.2M
Cap. Flow %
5.72%
Top 10 Hldgs %
40.34%
Holding
104
New
6
Increased
21
Reduced
24
Closed
10

Top Buys

Rank Stock Value
1
NOC icon
Northrop Grumman
NOC
+$7.97M
2
JPM icon
JPMorgan Chase
JPM
+$7.83M
3
ABBV icon
AbbVie
ABBV
+$6.04M
4
NVDA icon
NVIDIA
NVDA
+$4.32M
5
XLNX
Xilinx Inc
XLNX
+$4.13M

Top Sells

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$8.91M
2
DD icon
DuPont de Nemours
DD
+$6.22M
3
XOM icon
ExxonMobil
XOM
+$1.25M
4
PARA
Paramount Global Class B
PARA
+$780K
5
FTV icon
Fortive
FTV
+$486K

Sector Composition

Rank Sector Weight
1 Healthcare 30.55%
2 Technology 17.29%
3 Communication Services 13.62%
4 Industrials 12.57%
5 Energy 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBM icon
76
IBM
IBM
$222B
$276K 0.08%
2,092
– –
BRK.B icon
77
Berkshire Hathaway Class B
BRK.B
$1.08T
$256K 0.07%
1,200
-150
-11% -$31K
TJX icon
78
TJX Companies
TJX
$149B
$254K 0.07%
4,800
– –
ITOT icon
79
iShares Core S&P Total US Stock Market ETF
ITOT
$97.4B
$234K 0.07%
3,505
– –
LSXMA
80
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$202K 0.06%
7,405
– –
FSTX
81
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$193K 0.05%
13,084
– –
DVLT
82
Datavault AI
DVLT
$239M
– –
0
– –
BABA icon
83
Alibaba
BABA
$296B
– –
-1,149
Closed -$210K
DD icon
84
DuPont de Nemours
DD
$18.5B
– –
-46,113
Closed -$6.22M
IBB icon
85
iShares Biotechnology ETF
IBB
$10.5B
– –
-79,727
Closed -$8.91M
PARA
86
DELISTED
Paramount Global Class B
PARA
– –
-16,410
Closed -$780K
SIRI icon
87
SiriusXM
SIRI
$9.62B
– –
-1,721
Closed -$98K
TTWO icon
88
Take-Two Interactive
TTWO
$44B
– –
-4,070
Closed -$384K
XLV icon
89
State Street Health Care Select Sector SPDR ETF
XLV
$44.5B
– –
-4,220
Closed -$387K
CELG
90
DELISTED
Celgene Corp
CELG
– –
-2,140
Closed -$202K
1 2 3
4

Similar funds

SC
Shellback Capital Boston, Massachusetts $1.14B AUM 49.89% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
RIM
RW Investment Management Eagle, Idaho $1.14B AUM
VCP
Vista Capital Partners Portland, Oregon $1.14B AUM 21.34% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
SIM
Symetra Investment Management Farmington, Connecticut $1.14B AUM 10.76% 1-Year Est. Return

Private Capital Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Private Capital Advisors held 104 positions worth $353M, up 6.9% from $330M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Private Capital Advisors deployed $20.2M of net new capital in Q2 2019, opening 6 new positions and adding to 21 existing holdings. Its largest new stake was Northrop Grumman: 26,750 shares worth $8.64M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 31% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was ExxonMobil, an estimated $1.25M trimmed.

  • Private Capital Advisors's largest Q2 2019 buy was Northrop Grumman: 26,750 shares worth $8.64M.
  • Private Capital Advisors added most to AbbVie in Q2 2019, an estimated $6.04M increase.
  • Private Capital Advisors's biggest Q2 2019 reduction was ExxonMobil, cutting an estimated $1.25M.
  • Private Capital Advisors fully exited iShares Biotechnology ETF in Q2 2019, selling an estimated $8.91M.
  • Private Capital Advisors's ten largest holdings make up 40% of its $353M portfolio in Q2 2019.
  • Private Capital Advisors opened 6 new positions and closed 10 in Q2 2019.
  • Private Capital Advisors's portfolio value rose 6.9% quarter-over-quarter to $353M.

Based on Private Capital Advisors's 13F filing for Q2 2019, filed 18 Jul 2019.